Xueying Li Selected Research

Cisplatin (Platino)

1/2020	Long-Term Survival of Patients With Chemotherapy-Naïve Metastatic Nasopharyngeal Carcinoma Receiving Cetuximab Plus Docetaxel and Cisplatin Regimen.
11/2019	Tannic acid synergistically enhances the anticancer efficacy of cisplatin on liver cancer cells through mitochondria‑mediated apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xueying Li Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 11/2012
7	Vasovagal Syncope 01/2022 - 07/2009
6	Inflammation (Inflammations) 01/2022 - 12/2017
6	Epilepsy (Aura) 01/2021 - 01/2019
6	Postural Orthostatic Tachycardia Syndrome 01/2015 - 02/2012
5	Infections 07/2021 - 01/2017
4	Fibrosis (Cirrhosis) 01/2022 - 01/2013
4	Syncope (Fainting) 01/2022 - 07/2009
4	Spinal Cord Injuries (Spinal Cord Injury) 11/2020 - 05/2015
4	Adenocarcinoma of Lung 02/2020 - 12/2016
4	Lymphoma (Lymphomas) 04/2016 - 11/2014
3	Pain (Aches) 01/2021 - 03/2014
3	Reperfusion Injury 01/2021 - 01/2014
3	Lung Neoplasms (Lung Cancer) 02/2020 - 11/2014
3	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2012
3	IGA Glomerulonephritis (IGA Nephropathy) 01/2016 - 01/2013
2	Asthma (Bronchial Asthma) 02/2022 - 01/2020
2	Prostatic Neoplasms (Prostate Cancer) 02/2021 - 04/2020
2	Seizures (Absence Seizure) 01/2021 - 01/2019
2	Chronic Renal Insufficiency 11/2020 - 01/2013
2	Thrombocytopenia (Thrombopenia) 01/2020 - 12/2018
2	Pre-Eclampsia (Preeclampsia) 01/2020 - 01/2016
2	Carcinogenesis 09/2019 - 10/2015
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2019 - 12/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 01/2019
2	Chronic Hepatitis B 01/2018 - 01/2017
2	Hypoxia (Hypoxemia) 12/2017 - 05/2017
2	Pulmonary Arterial Hypertension 05/2017 - 07/2010
2	Wounds and Injuries (Trauma) 04/2017 - 01/2017
2	Glaucoma 02/2015 - 01/2014
2	Atrophy 01/2014 - 01/2013
2	Cognitive Dysfunction 07/2009 - 07/2008
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2022
1	Spontaneous Fractures (Pathological Fracture) 04/2022
1	Atopic Dermatitis (Atopic Eczema) 02/2022
1	Body Weight (Weight, Body) 01/2022
1	Disease Progression 12/2021
1	Rupture 11/2021
1	Chorioamnionitis 11/2021
1	Thyroid Nodule (Nodule, Thyroid) 11/2021
1	Thyroid Neoplasms (Thyroid Cancer) 11/2021
1	Huntington Disease (Huntington's Disease) 10/2021
1	Pneumonia (Pneumonitis) 07/2021

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2014
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2015
6	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2017
5	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2022 - 01/2015
4	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
4	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020 - 04/2017
3	IntegrinsIBA 01/2022 - 11/2014
3	Neuroprotective AgentsIBA 01/2021 - 04/2017
3	Retinaldehyde (Retinal)IBA 11/2020 - 01/2014
3	CytokinesIBA 01/2020 - 03/2019
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 10/2015 - 02/2012
3	Midodrine (Midon)FDA LinkGeneric 04/2014 - 07/2012
2	AntibodiesIBA 11/2021 - 01/2021
2	SaltsIBA 01/2021 - 01/2015
2	C-Reactive ProteinIBA 01/2021 - 06/2020
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 12/2016
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2017
2	SteroidsIBA 10/2020 - 05/2016
2	AlbuminsIBA 06/2020 - 10/2018
2	Messenger RNA (mRNA)IBA 02/2020 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 11/2019
2	EnzymesIBA 01/2020 - 03/2014
2	Biological ProductsIBA 01/2020 - 11/2018
2	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 01/2019
2	Small Interfering RNA (siRNA)IBA 12/2019 - 05/2015
2	Rituximab (Mabthera)FDA Link 07/2019 - 12/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2019 - 12/2014
2	Vincristine (Oncovin)FDA LinkGeneric 07/2019 - 12/2014
2	Prednisone (Sone)FDA LinkGeneric 07/2019 - 12/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2019 - 12/2014
2	mitochondrial K(ATP) channelIBA 12/2017 - 05/2017
2	PotassiumIBA 05/2017 - 03/2016
1	Metformin (Glucophage)FDA LinkGeneric 05/2022
1	4- (benzylamino)- 2- ((2- (3- chloro- 4- hydroxyphenyl)ethyl)amino)pyrimidine- 5- carboxamideIBA 02/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	CollagenIBA 01/2022
1	N-methyladenosineIBA 01/2022
1	CarcinogensIBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	6-methyladenineIBA 01/2022
1	Dinoprostone (PGE2)FDA Link 11/2021
1	Oxytocin (Pitocin)FDA LinkGeneric 11/2021
1	Galectin 3 (LGALS3)IBA 11/2021
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2021

Therapy/Procedure

17	Therapeutics 01/2022 - 11/2012
6	Drug Therapy (Chemotherapy) 02/2020 - 11/2014
3	Ambulatory Care (Outpatient Care) 08/2015 - 07/2008
2	Prostatectomy (Retropubic Prostatectomy) 02/2021 - 04/2020
2	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 01/2020
1	Conservative Treatment 04/2022
1	Duration of Therapy 01/2022
1	Induced Labor 11/2021